Great West Life Assurance CO Intercept Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$11.61 - $16.11 $26,192 - $36,344	-2,256 Reduced 54.39%	1,892 $24,000
Q3 2022 Nov 01, 2022	BUY	$12.21 - $19.7 $50,647 - $81,715	4,148 New	4,148 $58,000
Q2 2022 Aug 09, 2022	SELL	$11.23 - $19.59 $11,196 - $19,531	-997 Reduced 56.42%	770 $11,000
Q4 2019 Feb 11, 2020	BUY	$57.36 - $124.1 $23,804 - $51,501	415 Added 30.7%	1,767 $218,000
Q3 2019 Oct 25, 2019	SELL	$58.69 - $80.46 $70,251 - $96,310	-1,197 Reduced 46.96%	1,352 $90,000
Q2 2019 Jul 31, 2019	SELL	$77.77 - $120.68 $9,487 - $14,722	-122 Reduced 4.57%	2,549 $0
Q4 2018 Feb 12, 2019	BUY	$85.79 - $126.46 $58,508 - $86,245	682 Added 34.29%	2,671 $260,000
Q3 2017 Nov 09, 2017	BUY	$57.01 - $118.75 $113,392 - $236,193	1,989	1,989 $114,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.